Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke "CONVINCE"


Phase 3 Results N/A

Summary of Purpose

This study evaluates the use of Colchicine in adults over 40 years of age who have suffered an ischaemic stroke or transient ischaemic attack NOT caused by cardiac embolism or other defined causes. Patients will be randomised to 0.5 mg/day of Colchicine plus usual care, or to usual care alone. To investigate the efficacy of low dose colchicine (0.5mg/day) plus usual care (defined as antiplatelet,...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2017.

12 Dec 2016 8 Sep 2016 1 Oct 2021 1 Oct 2021 1 Sep 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment